WHO launches emergency response to drug resistance
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 25 Apr, 2013
Singapore: On World Malaria Day, April 25, the WHO recognized significant accomplishments made in preventing and control...Read more
Roche study: Obinutuzumab better than Rituxan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2013
Singapore: Roche reported that an independent data monitoring committee has obtained positive results from the phase III...Read more
Astellas, KEK sign deal for neglected diseases research
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Sep, 2012
Singapore: The High Energy Accelerator Research Organization (KEK) and Japan-based Astellas Pharma have concluded an agr...Read more
Alzheimer's research gets a push from Servier
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Oct, 2012
Singapore: Research on treatment of Alzheimer's disease received a fillip with Australian scientists working on it recei...Read more
Brisbane biotech secures $14 mn for drug discovery
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2013
Singapore: The University of Queensland-based biotechnology company Protagonist Therapeutics has secured $14 million in ...Read more
NZ firm migrates to Aus to capitalize on MS drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2013
Singapore: New Zealand-based biopharmaceutical company Innate Immunotherapeutics is migrating to Australia in a move to ...Read more
Dengue incurs annual cost of $950 mn to SE Asia
Drug Discovery | Analysis | By BioSpectrum Bureau | 3 Comment | 20 Jun, 2014
Philippines: The economic burden churned by mosquito borne disease, dengue, is costing upto $950 million to south east A...Read more
NSC lung cancer drug pipeline is strong: Analyst
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 11 Nov, 2014
Singapore: Non-Small Cell Lung Cancer (NSCLC) treatment pipeline has a diverse selection of 122 first-in-class products ...Read more
Are declining Ebola cases a challenge for clinical studies?
Drug Discovery | Analysis | By BioSpectrum Bureau | 3 Comment | 16 Mar, 2015
Singapore: The steady decline in new ebola cases presents a formidable challenge to current and future clinical trials o...Read more
BMS releases $3.5 mn fund for Hep B&C in India, China
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Dec, 2014
Singapore: Bristol-Myers-Squibb Foundation has released nine new grants totaling to around $3.5 million towards hepatiti...Read more
AMRI acquires Cedarburg at $41mn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Apr, 2014
Singapore: AMRI has completed the acquisition of Cedarburg Pharmaceuticals, a contract developer and manufacturer of tec...Read more
Latanoprost improves glucose, lipid disorder in diabetes
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2013
Singapore: Researchers from Shanghai Institute of Materia Medica, Chinese Academy of Science, have discovered that Latan...Read more
QRxPharma refiles Moxduo NDA with FDA
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Nov, 2013
Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...Read more
Eli Lilly partners with BioNTech to develop cancer immunotherapies
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 May, 2015
Singapore: Eli Lilly has partnered with German firm, BioNTech, to discover novel cancer immunotherapies through body's o...Read more
Boehringer Ingelheim collaborates with Harvard University
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2012
Singapore: Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows o...Read more
Zydus Cadila launches indigenous diabetes drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Sep, 2013
Singapore: Indian pharma company Cadila Healthcare that operates under the aegis of Zydus Group, has launched its patent...Read more
Astellas receives approval of Irribow in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Aug, 2013
Singapore: Astellas Pharma has obtained the marketing approval of Irribow OD 1 Tablets 2.5µg / 5µg (generic name: ramo...Read more
Biotron to report data from hepatitis C trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Oct, 2012
Singapore: Biotron, a clinical-stage drug development company focused on development of new generation antiviral drugs, ...Read more